CFO4Life Group LLC Has $2.81 Million Stock Holdings in Procter & Gamble Company (The) $PG

CFO4Life Group LLC reduced its stake in shares of Procter & Gamble Company (The) (NYSE:PGFree Report) by 3.7% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 17,638 shares of the company’s stock after selling 682 shares during the quarter. CFO4Life Group LLC’s holdings in Procter & Gamble were worth $2,810,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of PG. Kingstone Capital Partners Texas LLC lifted its holdings in shares of Procter & Gamble by 655,209.0% during the 2nd quarter. Kingstone Capital Partners Texas LLC now owns 76,028,952 shares of the company’s stock worth $11,832,680,000 after acquiring an additional 76,017,350 shares during the period. Nuveen LLC acquired a new position in Procter & Gamble during the first quarter valued at approximately $1,954,941,000. Price T Rowe Associates Inc. MD lifted its stake in Procter & Gamble by 13.0% during the first quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company’s stock worth $3,660,737,000 after purchasing an additional 2,466,308 shares during the last quarter. Invesco Ltd. boosted its holdings in shares of Procter & Gamble by 19.8% in the 1st quarter. Invesco Ltd. now owns 13,493,604 shares of the company’s stock valued at $2,299,580,000 after purchasing an additional 2,228,151 shares in the last quarter. Finally, Valeo Financial Advisors LLC increased its stake in shares of Procter & Gamble by 1,875.5% in the 2nd quarter. Valeo Financial Advisors LLC now owns 1,763,404 shares of the company’s stock valued at $280,946,000 after purchasing an additional 1,674,139 shares during the last quarter. Institutional investors and hedge funds own 65.77% of the company’s stock.

Insider Buying and Selling

In other news, insider Balaji Purushothaman sold 490 shares of the firm’s stock in a transaction dated Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total transaction of $74,592.70. Following the completion of the transaction, the insider directly owned 12,616 shares in the company, valued at $1,920,533.68. This trade represents a 3.74% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, COO Shailesh Jejurikar sold 3,986 shares of the company’s stock in a transaction that occurred on Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total value of $606,788.78. Following the completion of the sale, the chief operating officer owned 46,899 shares in the company, valued at $7,139,434.77. The trade was a 7.83% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders have sold 150,489 shares of company stock valued at $23,529,864. Corporate insiders own 0.20% of the company’s stock.

Analysts Set New Price Targets

Several analysts recently weighed in on the company. Morgan Stanley set a $175.00 price objective on Procter & Gamble in a research report on Monday, October 27th. Barclays dropped their target price on shares of Procter & Gamble from $164.00 to $153.00 and set an “equal weight” rating for the company in a report on Wednesday, October 1st. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Procter & Gamble in a report on Thursday. Bank of America lowered their price objective on shares of Procter & Gamble from $180.00 to $174.00 and set a “buy” rating for the company in a research report on Wednesday, October 8th. Finally, Wells Fargo & Company cut their target price on shares of Procter & Gamble from $173.00 to $170.00 and set an “overweight” rating on the stock in a research report on Thursday, September 25th. Twelve analysts have rated the stock with a Buy rating and nine have given a Hold rating to the stock. According to data from MarketBeat.com, Procter & Gamble has a consensus rating of “Moderate Buy” and a consensus target price of $171.53.

View Our Latest Stock Analysis on Procter & Gamble

Procter & Gamble Stock Down 0.2%

NYSE:PG opened at $147.71 on Friday. Procter & Gamble Company has a one year low of $144.09 and a one year high of $180.43. The company has a debt-to-equity ratio of 0.46, a current ratio of 0.71 and a quick ratio of 0.51. The company has a market cap of $345.16 billion, a PE ratio of 21.56, a P/E/G ratio of 3.87 and a beta of 0.36. The firm’s 50 day simple moving average is $151.83 and its 200 day simple moving average is $156.61.

Procter & Gamble (NYSE:PGGet Free Report) last released its quarterly earnings results on Friday, October 24th. The company reported $1.99 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.90 by $0.09. The firm had revenue of $22.39 billion during the quarter, compared to the consensus estimate of $22.23 billion. Procter & Gamble had a net margin of 19.74% and a return on equity of 32.63%. The company’s revenue for the quarter was up 3.0% on a year-over-year basis. During the same quarter last year, the firm earned $1.93 earnings per share. Procter & Gamble has set its FY 2026 guidance at 6.830-7.100 EPS. On average, research analysts anticipate that Procter & Gamble Company will post 6.91 earnings per share for the current year.

Procter & Gamble Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, November 17th. Shareholders of record on Friday, October 24th will be given a $1.0568 dividend. This represents a $4.23 dividend on an annualized basis and a dividend yield of 2.9%. The ex-dividend date is Friday, October 24th. Procter & Gamble’s payout ratio is 61.61%.

Procter & Gamble Company Profile

(Free Report)

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.

Recommended Stories

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.